XELIRI

Capecitabine (Xeloda), Irinotecan · Oral/IV Colorectal Regimen

Back to Cancer Drug Encyclopedia Find Recruiting Trials with this Drug →

Indications & Uses

First-line or second-line treatment of Metastatic Colorectal Cancer.

Contraindications

DPD enzyme deficiency, severe renal impairment.

Side Effects & Warnings

Severe diarrhea, hand-foot syndrome, neutropenia, nausea, vomiting.

Drug & Dietary Interactions

Extensive interactions; consult specific multi-agent administration and hydration protocols.

For educational and informational purposes only. Do not alter medication doses or regimens without consulting your licensed oncology physician or care team.

Patient & Caregiver Support

Ask About This Medication

Connect with an ONC-ORG counselor regarding drug access, copay relief, patient assistance programs, or related clinical trials.